Search
Raji Reddy Kesireddy / ETHealthworld.com
2 min read
India to open drugs database to global regulators
India had exported medicines worth $15.2 billion (about Rs 97,000 crore) in 2014-15, an increase of 5% over the previous year’s figure....
ET HealthWorld.com
2 min read
Indian government plans to set up Rs 500 crore VC fund for pharma industry
The Indian government plans to set up Rs 500 crore venture capital fund to boost domestic pharma industry and provide cheaper loans to...
R. Hernandez
12 min read
Top Trends in Biopharmaceutical Manufacturing: 2015
New cell-culture techniques, biomanufacturing formats, biological products, and the expansion of single-use applications are driving...
Matthew Herper Forbes Staff / March 2
9 min read
The Coming Boom In Brain Medicines
Tony Coles could have had any job he wanted in the drug industry. In five years at the helm of cancer drug developer Onyx Pharmaceuticals...
Healio.com
2 min read
FDA issues draft guidance on nonproprietary naming of biosimilars
The FDA announced the availability of a draft guidance describing its proposal on the nonproprietary naming of biological products....
by Vera Weinstein PhD
6 min read
Looking at the Recent FDA Biosimilar Guidelines
Small-molecule treatments are invaluable in providing symptomatic benefits for an array of illnesses. However, many serious conditions —...
byHemant Ahlawat, Giulia Chierchia
1 min read
The secret of successful drug launches
About two-thirds of drug launches don’t meet expectations. Improving that record requires pharmaceutical companies to recognize the world...
Terry Graedon
2 min read
Why Don’t You Trust Generic Drugs as Much as Brand Name Medicines?
From www.peoplespharmacy.com Why don’t patients and their doctors trust generic drugs? Despite the fact that 84 percent of all...
selected & edited by #pharmanaming.com
2 min read
Double Trouble: Consumer awareness of look-alike names
From www.consumermedsafety.org Coming up with a name for a new medicine isn’t as easy as you think. Drug companies look for names that...
By Bernard Murphy / The Pharmaceutical Journal /
9 min read
Debate over naming of biosimilars intensifies ahead of WHO meeting
Healthcare payers are gearing up for huge savings from a slew of new biosimilars due to hit the market, but regulators are debating how...